Health Care: Drugs

AVANIR Pharmaceuticals (AVNR: NASDAQ)

$16.92 0.01 | 0.06%
12/26/14 - 04:00 PM ET
Company Income Statement
Sep 2014 Sep 2013 Sep 2012 Sep 2011
Sales 115.03M 75.37M 41.28M 10.50M
Cost of Sales 1.72M 2.73M 1.21M 8.14K
Gross Operating Profit 113.31M 72.64M 40.07M 10.49M
Selling, General, and Administrative Expenses 113.85M 93.14M 74.49M 55.43M
Research & Development 44.00M 49.51M 23.07M 15.25M
Operating Income before D & A (EBITDA) -44.54M -70.00M -57.49M -60.19M
Depreciation & Amortization 1.80M 1.42M 913.06K 437.84K
Interest Income 20.00K 51.91K 42.82K 38.78K
Other Income - Net -797.00K -31.00 4.08K -37.73K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -47.12M -71.37M -58.36M -60.63M
Interest Expense 3.31M 4.10M 1.39M 0.00
Pre-Tax Income -50.43M -75.47M -59.74M -60.63M
Income Taxes 3.00K 3.20K 3.20K 3.20K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -50.44M -75.48M -59.74M -60.63M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -50.44M -75.48M -59.74M -60.63M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -50.44M -75.48M -59.74M -60.63M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-50.44M -75.48M -59.74M -60.63M
Preferred Dividends
Net Income Available To Common -50.44M -75.48M -59.74M -60.63M
Basic EPS from Continuing Ops. -0.31 -0.53 -0.45 -0.51
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.31 -0.53 -0.45 -0.51
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.31 -0.53 -0.45 -0.51
Basic Normalized Net Income/Share -0.31 -0.53 -0.45 -0.51
EPS fr Continuing Ops. -0.31 -0.53 -0.45 -0.51
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.31 -0.53 -0.45 -0.51
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.31 -0.53 -0.45 -0.51
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.31 -0.53 -0.45 -0.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AVNR

Latest AVNR Headlines from TheStreet

More Financial News for AVNR

Press Releases for AVNR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter